Indhu-Shree Rajan-Babu1,2, Junran J Peng3, Readman Chiu4, Chenkai Li4,5, Arezoo Mohajeri3, Egor Dolzhenko6, Michael A Eberle6, Inanc Birol3,4, Jan M Friedman3. 1. Department of Medical Genetics, University of British Columbia and Children's & Women's Hospital, Vancouver, BC, V6H3N1, Canada. indhu.babu@bcchr.ca. 2. Department of Medical and Molecular Genetics, King's College London, Strand, London, WC2R 2LS, UK. indhu.babu@bcchr.ca. 3. Department of Medical Genetics, University of British Columbia and Children's & Women's Hospital, Vancouver, BC, V6H3N1, Canada. 4. Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, V5Z4S6, Canada. 5. Bioinformatics Graduate Program, University of British Columbia, Vancouver, BC, V6T1Z4, Canada. 6. Illumina Inc., San Diego, CA, 92121, USA.
Correction to: Genome Med 13, 126 (2021)https://doi.org/10.1186/s13073-021-00932-9It was highlighted that in the original article [1] the list of the authors belonging in the IMAGINE and CAUSES Study were erroneously interchanged. The original article has been updated.AcknowledgementsWe would like to thank all the CAUSES and IMAGINE Study investigators. CAUSES Study investigators include Shelin Adam, Christele Du Souich, Alison Elliott, Anna Lehman, Jill Mwenifumbo, Tanya Nelson, Clara van Karnebeek, Rajan-Babu et al. Genome Medicine (2021) 13:126 Page 13 of 15 and Jan Friedman. The CAUSES Study is funded by Mining for Miracles, British Columbia Children’s Hospital Foundation, and Genome British Columbia. IMAGINE Study investigators include Patricia Birch, Madeline Couse, Colleen Guimond, Anna Lehman, Jill Mwenifumbo, Clara van Karnebeek, and Jan Friedman. We thank Compute Canada for the Research Allocation Competitions allocation, which facilitated our analysis of the IMAG INE and EGA genomes, and Julia Handra for coordinating the STR molecular testing of the clinical samples.